tradingkey.logo

ENDRA Life Sciences Inc

NDRA
View Detailed Chart

4.840USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
2.72MMarket Cap
LossP/E TTM

ENDRA Life Sciences Inc

4.840

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-8.33%

5 Days

-26.67%

1 Month

+36.72%

6 Months

-2.81%

Year to Date

-22.68%

1 Year

-96.43%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
BUY
Current Rating
46.000
Target Price
850.41%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
ENDRA Life Sciences Inc
NDRA
1
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(2)
Buy(2)
Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.715
Neutral
RSI(14)
40.107
Neutral
STOCH(KDJ)(9,3,3)
3.608
Oversold
ATR(14)
0.608
High Vlolatility
CCI(14)
-165.816
Sell
Williams %R
98.788
Oversold
TRIX(12,20)
1.075
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
5.544
Sell
MA10
6.074
Sell
MA20
6.769
Sell
MA50
4.739
Buy
MA100
4.451
Buy
MA200
5.185
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Ticker SymbolNDRA
CompanyENDRA Life Sciences Inc
CEOMr. Alexander Y. Tokman
Websitehttps://www.endrainc.com/
KeyAI